Core Viewpoint - Go Metals Corp. has acquired five new projects in Ontario and Quebec through its subsidiary, Deep Hydrogen Corp., focusing on geologic hydrogen exploration in the Canadian Shield [1][3]. New Projects - The company has staked five new claim blocks totaling 5,641 hectares, with a detailed catalogue of surficial hydrogen indicators developed using AI and traditional prospecting techniques [4][6]. - The Hydra project spans 1,987 hectares and is located near favorable ultramafic and mafic lithologies, with good access to infrastructure [4]. - The Fornax project covers 1,049 hectares and is centered on an underexplored ultramafic intrusion, showing promise for exploration [5][7]. - The Ursa project, at 812 hectares, is situated near Timmins, Ontario, and features structural complexity and ultramafic rocks [7]. - The Aquila project, covering 626 hectares, targets deep faults and ultramafic dikes associated with the Mid-Continent Rift [8]. - The Cygnus project spans 1,167 hectares and is located near the Montviel carbonatite complex, providing accessible exploration opportunities [9]. Spring Work Programs - Upcoming programs will focus on testing gas accumulation at the surface using multispectral satellite data, soil gas sampling, and long-term monitoring in promising areas [10]. Hydrogen Potential in the Canadian Shield - The Canadian Shield consists of Precambrian crystalline basement rocks rich in ultramafic and mafic minerals, which can produce natural hydrogen through the process of serpentinization [11]. Forest Rings as a Pathfinder for Natural Hydrogen - Forest rings, circular patterns of stressed vegetation, may indicate the presence of hydrogen at depth, and the company plans to test these areas for potential links to natural hydrogen [12][13]. Hydrogen Project Regulations - The regulatory framework for hydrogen exploration in Canada is still evolving, and the company is engaging with provincial authorities to ensure compliance with regulations [14]. About Go Metals and Deep Hydrogen - Go Metals is focused on critical mineral exploration and utilizes AI tools for exploration under the GeoDL banner. Its subsidiary, Deep Hydrogen Corp., is dedicated to exploring natural hydrogen in the Canadian Shield [16].

Group 1 - The article discusses the author's background in church work and education, highlighting a transition to a different career path after earning an MBA in 2015 [1] - The author currently resides in the Midwest with family and a pet cat, indicating a personal aspect of their life [1] Group 2 - The article includes a disclosure regarding a long position in GOCO shares, indicating a vested interest in the company's performance [2] - The author also holds a long position in CVS Health, which operates Aetna health insurance, including Medicare Advantage plans, suggesting a focus on the healthcare sector [2]

Third Quarter 2024 Results November 7, 2024 FORWARD-LOOKING STATEMENTS 2 This earnings presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These forward-looking statements are made in reliance upon the safe harbor provision of the Private Securities Litigation Reform Act of 1995. All statements other than statements of histo ...

Financial Data and Key Metrics Changes - GoHealth achieved net revenues of $118.3 million in Q3 2024, down from $132 million in the same period last year [40] - Adjusted EBITDA for the quarter was negative $12.1 million, a slight decrease of $600,000 compared to the prior year [42] - Positive cash flow from operations for the trailing 12 months was $35.1 million, an increase of $38.3 million compared to the prior year [43] Business Line Data and Key Metrics Changes - Internal captive agent submissions increased by 46% year-over-year, while submissions from the GPS channel declined by 46% [40][17] - Overall submissions were up 3% year-over-year, with internal captive agent submissions driving this growth [17] Market Data and Key Metrics Changes - The market dynamics have been stagnant through Q3, but improvements are anticipated in Q4 due to new benefits and significant benefit disruption [19] - Over 2 million individuals lost coverage, and more than 6 million consumers saw reduced plan benefits, driving increased shopping for new plan options [27] Company Strategy and Development Direction - GoHealth aims to empower Medicare consumers with proprietary technological tools and a highly trained agency, transitioning from a traditional enrollment company to a Medicare engagement company [13] - The acquisition of e-TeleQuote is expected to enhance operational capacity and market leadership, adding approximately $90.5 million in contract assets and $22.5 million in cash to the balance sheet [21][23] - The company is focused on reducing direct operating costs per submission through AI and automation, with a goal of improving marketing efficiency and operational performance [33][36] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the upcoming annual enrollment period (AEP), anticipating strong demand and improved submissions revenue [28][50] - The company remains committed to delivering exceptional service to Medicare consumers and adapting to changes in the regulatory landscape [56][57] Other Important Information - GoHealth completed the refinancing of its term loan credit facility, extending the maturity through November 2029 and improving financial terms [47][48] - The company is strategically deploying cash to seize growth opportunities in the current favorable market conditions [44][50] Q&A Session Summary Question: Readiness of new agents from e-TeleQuote for AEP - Management expressed confidence in the seasoned and skilled team from e-TeleQuote, highlighting effective training and onboarding processes [59][60] Question: Plans for additional debt paydowns and target debt to EBITDA ratio - Management indicated a flexible approach to capital deployment, focusing on growth opportunities while evaluating debt paydown strategies [61][62] Question: Sustainability of internal captive agent submissions growth - Management noted that the growth in internal submissions is expected to continue due to enhanced efficiency and targeted marketing efforts [67][70] Question: Impact of cash flow improvements - Management clarified that operational efficiencies were the primary driver of cash flow improvements, rather than the agency versus non-agency mix [74][76] Question: Efforts to reduce customer acquisition costs (CAC) - Management discussed ongoing improvements in marketing targeting and technology efficiency to reduce CAC, with a focus on balancing efficiency and consumer support [78][80] Question: Future opportunities for acquisitions similar to e-TeleQuote - Management acknowledged the potential for further acquisitions, emphasizing the importance of technology and operational synergies [85][86] Question: Anticipated agency versus non-agency mix going forward - Management explained that the mix will depend on market conditions and consumer needs, allowing for flexibility in product offerings [87][90] Question: Impact of the recent election on the business - Management stated that they are prepared to adapt to changes from the new administration while continuing to focus on serving Medicare consumers [92][94] Question: Cash deployment strategy over the next six months - Management indicated a focus on extending agent availability and enhancing marketing efforts to meet consumer demand [95][96]

Financial Performance - Net revenues for Q3 2024 were $118.292 million, a decrease of 10.5% from $132.037 million in Q3 2023[28]. - The company reported a net income of $15.366 million in Q3 2024, compared to a net loss of $56.204 million in Q3 2023[28]. - Comprehensive income attributable to GoHealth, Inc. was $6,784 thousand for the three months ended September 30, 2024, compared to a loss of $23,849 thousand in the same period of the previous year[29]. - GoHealth, Inc. reported a net income of $15,366 thousand for the three months ended September 30, 2024, compared to a net loss of $56,204 thousand for the same period in 2023, marking a significant turnaround[29]. - The net income per share of Class A common stock was $0.58 for Q3 2024, a significant improvement from a loss of $2.61 per share in Q3 2023[28]. - The company reported a comprehensive loss of $65,326 thousand for the nine months ended September 30, 2024, compared to a loss of $148,787 thousand for the same period in 2023[29]. - GoHealth reported a net loss of $65.294 million for the nine months ended September 30, 2024, compared to a net loss of $148.976 million for the same period in 2023, indicating a significant improvement[35]. Revenue and Expenses - Total operating expenses for Q3 2024 were $160.964 million, down from $170.013 million in Q3 2023, reflecting a reduction of 5.9%[28]. - The company experienced a significant reduction in revenue share expenses, which were $19.683 million in Q3 2024 compared to $35.992 million in Q3 2023, a decrease of 45%[28]. - Marketing and advertising expenses increased to $45.270 million in Q3 2024 from $39.416 million in Q3 2023, representing a rise of 14.7%[28]. - The company experienced a share-based compensation expense of $6.534 million for the nine months ended September 30, 2024, down from $15.298 million in the prior year[35]. - General and administrative expenses for the three months ended September 30, 2024, were $17.1 million, an increase of $4.2 million or 32.2% compared to the prior year[167]. - Interest expense for the three months ended September 30, 2024, was $19.1 million, an increase of $1.5 million or 8.7% year-over-year[170]. Assets and Liabilities - Total current assets decreased to $334,043 thousand as of September 30, 2024, down from $476,440 thousand at the end of 2023, primarily due to a reduction in cash and cash equivalents[30]. - The company’s total assets decreased to $1,341,153 thousand as of September 30, 2024, compared to $1,499,570 thousand at December 31, 2023, reflecting a decline of approximately 10.6%[30]. - Cash and cash equivalents significantly decreased to $35,527 thousand as of September 30, 2024, from $90,809 thousand at December 31, 2023, indicating a liquidity challenge[30]. - The company’s accumulated deficit increased to $448,717 thousand as of September 30, 2024, compared to $420,280 thousand at the end of 2023, reflecting ongoing financial pressures[30]. - Total stockholders' equity attributable to GoHealth, Inc. decreased to $212,040 thousand as of September 30, 2024, from $231,014 thousand at the end of 2023, a decline of approximately 8.2%[30]. Debt and Financing - As of September 30, 2024, total long-term debt amounted to $416.3 million, down from $422.7 million as of December 31, 2023[61]. - The effective interest rate on Term Loan Facilities was 13.4% as of September 30, 2024, compared to 13.0% as of December 31, 2023[63]. - Future maturities of debt include $25.0 million due in the fourth quarter of 2024 and $40.0 million due in 2025[61]. - The principal amount outstanding under Term Loan Facilities was $99.5 million, $266.8 million, and $86.5 million for different loan categories as of September 30, 2024[203]. - The Company had $40.0 million outstanding under the Revolving Credit Facilities as of September 30, 2024, with a remaining capacity of $48.5 million[205]. Operational Metrics - Adjusted EBITDA margin is a key performance measure, calculated as Adjusted EBITDA divided by net revenues, providing insights into operational efficiency[19]. - Direct Operating Cost per Submission for the period is a critical metric for evaluating submission performance, reflecting the average cost associated with submissions generated[24]. - The number of Submissions for the nine months ended September 30, 2024, was 166,195, an increase of 2.9% from 161,550 in 2023[181]. - Sales per Submission for the three months ended September 30, 2024, decreased to $702, down 13.7% from $813 in the same period of 2023[188]. - Direct Operating Cost of Submission decreased to $110.2 million for the three months ended September 30, 2024, from $120.4 million in the prior year[193]. Market and Strategic Initiatives - The company aims to simplify the health insurance enrollment process for Medicare-eligible consumers through its technology-driven marketplace and licensed agents[36]. - The introduction of PlanFit CheckUp utilizes analytics from nearly 30 million consumer touchpoints to match consumers with suitable Medicare plans[150]. - The company is focusing on streamlining processes and improving call handle times through the launch of Encompass Express[152]. - The acquisition of e-TeleQuote Insurance, Inc. was completed on September 30, 2024, expanding agent capacity without the need for further hiring[155]. - The Company recognized a gain on bargain purchase of $77.4 million from the acquisition of e-TeleQuote Insurance, Inc., which is included in the Condensed Consolidated Statements of Operations[138].

Core Viewpoint - GoHealth reported a quarterly loss of $3.73 per share, which was worse than the Zacks Consensus Estimate of a loss of $3.19, and a significant increase from a loss of $2.61 per share a year ago, indicating ongoing financial challenges for the company [1] Financial Performance - GoHealth's revenues for the quarter ended September 2024 were $118.29 million, exceeding the Zacks Consensus Estimate by 11.67%, but down from $132.04 million in the same quarter last year [2] - Over the last four quarters, GoHealth has surpassed consensus EPS estimates only once [2] Stock Performance - GoHealth shares have declined approximately 4.4% since the beginning of the year, contrasting with the S&P 500's gain of 24.3% [3] Future Outlook - The company's earnings outlook will be crucial for its stock performance, with current consensus EPS estimates at $1.50 for the upcoming quarter and -$5.35 for the current fiscal year [4][7] - The estimate revisions trend for GoHealth is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] Industry Context - The Insurance - Life Insurance industry, to which GoHealth belongs, is currently ranked in the top 20% of over 250 Zacks industries, indicating a favorable industry outlook that could positively influence GoHealth's performance [8]

Financial Performance - Third quarter 2024 net revenues were $118.3 million, a decrease of $13.7 million compared to $132.0 million in the prior year period[3]. - Third quarter 2024 net income improved to $15.4 million, a $71.6 million increase from a net loss of $56.2 million in the prior year period[3]. - Adjusted EBITDA for the third quarter 2024 was negative $12.1 million, a decrease of $0.6 million compared to negative $11.5 million in the prior year period[3]. - The company reported a net income of $15,366 for the three months ended September 30, 2023, compared to a net loss of $56,204 in the prior year, representing a significant improvement[24]. - For the nine months ended September 30, 2023, net revenues were $409,762, a decrease of 10.5% from $457,974 in the same period last year[25]. - The adjusted EBITDA for the nine months ended September 30, 2023, was $2,479, a decrease from $18,091 in the prior year[25]. - The company reported an EBITDA of $60,860 for the three months ended September 30, 2024, compared to $(12,482) for the same period in 2023[26]. - The net income margin for the three months ended September 30, 2024, was 13.0%, compared to a net loss margin of (42.6)% for the same period in 2023[26]. Operational Metrics - Third quarter 2024 submissions increased by 2.9% to 166,195 from 161,550 in the prior year period, driven by internal captive agents[3]. - Direct Operating Cost per Submission improved by 11.0% in the third quarter 2024 compared to the prior year period, due to advancements in AI and operational efficiencies[3][4]. - Sales per submission decreased from $813 in the three months ended September 30, 2023, to $702 in the same period of 2024, a decline of 13.7%[31]. - Direct operating cost per submission decreased from $745 in the three months ended September 30, 2023, to $663 in the same period of 2024, a reduction of 11.0%[31]. - Direct operating cost of submission for the nine months ended September 30, 2024, was $346,112 thousand, down from $365,612 thousand in the same period of 2023[32]. - Sales/Direct operating cost of submission remained stable at 1.1 for the three months ended September 30, 2024, consistent with the same period in 2023[32]. Cash Flow and Assets - The trailing twelve months positive cash flow from operations was $35.1 million, an increase of $38.3 million compared to TTM negative cash flow of $3.2 million in the prior year period[3]. - Net cash used in operating activities for the nine months ended September 30, 2024, was $(36,211) thousand, compared to $37,840 thousand for the same period in 2023[30]. - Total current assets decreased from $476,440 thousand as of December 31, 2023, to $334,043 thousand as of September 30, 2024, a decline of approximately 29.9%[29]. - Total liabilities decreased from $1,499,570 thousand as of December 31, 2023, to $1,341,153 thousand as of September 30, 2024, a decline of approximately 10.6%[29]. - The accumulated deficit increased from $(420,280) thousand as of December 31, 2023, to $(448,717) thousand as of September 30, 2024[29]. - Total stockholders' equity attributable to GoHealth, Inc. decreased from $231,014 thousand as of December 31, 2023, to $212,040 thousand as of September 30, 2024[29]. Strategic Initiatives - The strategic acquisition of e-TeleQuote added approximately $90.5 million in contract assets and $22.5 million in cash, with a gain on bargain purchase of $77.4 million[3][4]. - GoHealth aims to leverage its expanded agent network and AI-driven technology to address the needs of over two million consumers losing coverage during the Medicare Annual Enrollment Period[4]. - The company appointed Brendan Shanahan as Chief Financial Officer, bringing over 30 years of healthcare and financial strategy expertise[3]. - GoHealth's investments in technology and agent capacity are expected to position the company for sustained growth and profitability amid market changes[4]. Expense Management - Total operating expenses for the three months ended September 30, 2023, decreased by 5.3% to $160,964, down from $170,013 year-over-year[24]. - Operating expenses for the nine months ended September 30, 2023, totaled $497,076, down 10.4% from $554,715 year-over-year[25]. - Marketing and advertising expenses increased by 14.9% to $45,270 for the three months ended September 30, 2023, compared to $39,416 in the same period last year[24]. - Marketing and advertising expenses for the three months ended September 30, 2024, decreased to $75 from $149 in the same period in 2023[28]. - Customer care and enrollment expenses for the three months ended September 30, 2024, were $189, down from $519 in the same period in 2023[28]. - Technology expenses for the three months ended September 30, 2024, were $293, a decrease from $676 in the same period in 2023[28]. - Total share-based compensation expense for the three months ended September 30, 2024, was $2,859, compared to a benefit of $(545) for the same period in 2023[28]. - Interest expense for the three months ended September 30, 2024, was $19,086, an increase from $17,565 in the same period in 2023[26].

CHICAGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- GoHealth Inc. (NASDAQ: GOCO) ("GoHealth" or the "Company") today announced Vijay Kotte, CEO of GoHealth, will present at the LD Micro Main Event Investor Conference on Tuesday, October 29th, 2024, at The Luxe Sunset Boulevard, Los Angeles, CA. The Company's presentation is scheduled to begin at 3:00 pm CT. The presentation will be webcast. Register to watch the virtual presentation here GOCO Investor Presentation at LD Micro Main Event. About GoHealth, Inc. GoHealt ...

CHICAGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced the appointment of Brendan Shanahan as Chief Financial Officer (CFO), effective October 14, following a comprehensive search process. Mr. Shanahan, a seasoned executive with over 30 years of financial leadership experience and over 20 years of expertise in the Medicare Advantage space, will oversee GoHealth's financial strategy and oper ...

Health insurance marketplace GoHealth has inked an agreement to buy Medicare-focused e-TeleQuote. The acquisition is expected to close Sept. 30, GoHealth said in a Wednesday (Sept. 4) news release. The company called the acquisition a "significant milestone in GoHealth's mission to deliver unparalleled consumer-centric solutions while reinforcing the companies' shared values of integrity, empathy, and accountability." GoHealth said both firms have deep industry expertise, and each has a "complementary set o ...